Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.

Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has removed detailed information about a global study of oral risdiplam for spinal muscular atrophy (SMA) in pre-symptomatic infants, including study design, inclusion and exclusion criteria, and treatment duration, while adding a new registry identifier and a revision number.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 20, 2025, and version 2.14.2.SummaryDifference0.2%
- Check45 days agoChange DetectedThe webpage has updated its location details for Orlando, Florida, and São Paulo, Brazil, along with changes to the associated hospitals. Additionally, the last update date has been revised to March 2025, reflecting a shift in the timeline for information availability.SummaryDifference3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.